TickerFacts.

Exagen Inc. (XGN): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$14.27M
Year ended 2025-12-31
-$7.59M
Trailing 12 months to 2026-06-30
2018-12-31: -$9.50M2019-12-31: -$10.11M2020-12-31: -$14.54M2021-12-31: -$22.64M2022-12-31: -$36.46M2023-12-31: -$15.29M2024-12-31: -$13.79M2025-12-31: -$14.27M-$14.27M
2018-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$14.27Mn/m2026-03-10, From 2025-01-01
2024-12-31-$13.79Mn/m2026-03-10, From 2024-01-01
2023-12-31-$15.29Mn/m2025-03-11, From 2023-01-01
2022-12-31-$36.46Mn/m2024-03-18, From 2022-01-01
2021-12-31-$22.64Mn/m2023-03-20, From 2021-01-01
2020-12-31-$14.54Mn/m2022-03-22, From 2020-01-01
2019-12-31-$10.11Mn/m2021-03-16, From 2019-01-01
2018-12-31-$9.50Mn/a2020-03-25, From 2018-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Exagen Inc. (XGN)2025-12-31-$14.27Mn/m
Personalis, Inc. (PSNL)2025-12-31-$79.45Mn/m
Biodesix Inc (BDSX)2025-12-31-$23.53Mn/m
GRAIL, Inc. (GRAL)2025-12-31-$299.92Mn/m
American Shared Hospital Services (AMS)2025-12-31-$4.54Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$15.71Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31-$124.21Mn/m
Castle Biosciences Inc (CSTL)2025-12-31$28.33M-22.5%
Veracyte, Inc. (VCYT)2025-12-31$126.63M+98.5%

Compare XGN, PSNL, BDSX, GRAL side by side · Screen every company in Services-Medical Laboratories ↗